Northern Trust Corp cut its holdings in Vitamin Shoppe, Inc (NYSE:VSI) by 6.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 272,859 shares of the specialty retailer’s stock after selling 19,444 shares during the period. Northern Trust Corp owned approximately 1.18% of Vitamin Shoppe worth $3,179,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of VSI. Vanguard Group Inc. boosted its holdings in Vitamin Shoppe by 14.8% in the first quarter. Vanguard Group Inc. now owns 2,186,549 shares of the specialty retailer’s stock worth $44,059,000 after purchasing an additional 282,598 shares in the last quarter. Canada Pension Plan Investment Board boosted its holdings in Vitamin Shoppe by 80.6% in the second quarter. Canada Pension Plan Investment Board now owns 236,900 shares of the specialty retailer’s stock worth $2,760,000 after purchasing an additional 105,700 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new stake in Vitamin Shoppe in the second quarter worth $877,000. Schwab Charles Investment Management Inc. boosted its holdings in Vitamin Shoppe by 34.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 262,123 shares of the specialty retailer’s stock worth $3,054,000 after purchasing an additional 67,362 shares in the last quarter. Finally, State Street Corp boosted its holdings in Vitamin Shoppe by 9.2% in the first quarter. State Street Corp now owns 721,483 shares of the specialty retailer’s stock worth $14,535,000 after purchasing an additional 60,575 shares in the last quarter. Hedge funds and other institutional investors own 85.35% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/24/northern-trust-corp-sells-19444-shares-of-vitamin-shoppe-inc-vsi.html.

A number of equities research analysts recently issued reports on the stock. ValuEngine cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Goldman Sachs Group, Inc. (The) reiterated a “sell” rating and issued a $6.00 price objective (down from $13.00) on shares of Vitamin Shoppe in a report on Thursday, August 10th. Morgan Stanley decreased their price objective on shares of Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating for the company in a report on Thursday, November 9th. TheStreet cut shares of Vitamin Shoppe from a “c-” rating to a “d” rating in a report on Wednesday, August 9th. Finally, Deutsche Bank AG reiterated a “hold” rating and issued a $7.00 price objective (down from $14.00) on shares of Vitamin Shoppe in a report on Thursday, August 10th. Four investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the stock. Vitamin Shoppe presently has a consensus rating of “Hold” and an average target price of $5.00.

Vitamin Shoppe, Inc (VSI) opened at $3.75 on Friday. The firm has a market cap of $89.92, a price-to-earnings ratio of 4.03 and a beta of 0.74. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59. Vitamin Shoppe, Inc has a 52-week low of $2.95 and a 52-week high of $26.25.

Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.20). The firm had revenue of $288.20 million for the quarter, compared to analyst estimates of $297.61 million. Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. The firm’s revenue was down 8.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.50 EPS. equities analysts expect that Vitamin Shoppe, Inc will post 0.44 earnings per share for the current year.

Vitamin Shoppe Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe, Inc (NYSE:VSI).

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Stock Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related stocks with our FREE daily email newsletter.